1. AB1148 ECONOMIC BENEFIT FROM IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE WITH UPADACITINIB AND COMPARISONS WITH TOFACITINIB AND METHOTREXATE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Bensimon, A.; Yang, M.; Orvis, E.; Clewell, J.; Tundia, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1864 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0115 Humira® (Adalimumab): Fifteen Years of Controlled Production and Consistency of Quality Attributes. (9th June 2015) Authors: Venema, J.; Tebbey, P.; Varga, A.; Naill, M.; Wang, X.; Cui, L.; Clewell, J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 461 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0156 Adalimumab treatment is associated with decreased concomitant RA medication use over 24 months. (23rd January 2014) Authors: Furst, D.E.; Mozaffarian, N.; Grant, S.; Cifaldi, M.; Clewell, J.; Kremer, J.; Shaw, J.W. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0546 HEALTHCARE COSTS OF NOT ACHIEVING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS. (2nd June 2020) Authors: Bergman, M.; Zhou, L.; Patel, P.; Sawant, R.; Clewell, J.; Tundia, N. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗